Insiders Cellectar Biosciences, Inc.

Equities

CLRB

US15117F8077

Real-time Estimate Cboe BZX Other stock markets 09:31:23 27/06/2024 pm IST			5-day change	1st Jan Change
2.51 ^USD	-13.15%		-8.93%	-7.94%

29/05	Cellectar Biosciences, Inc. and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis fungoides	CI
14/05	Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cellectar Biosciences Hires Dr. Andrei Shustov as New Senior Vice President, Medical	15/23/15	CI
Cellectar Biosciences, Inc. Announces Appointment of Shane Lea as Chief Commercial Officer	30/22/30	CI
Femasys Names Dov Elefant as CFO	24/22/24	MT
Cellectar Biosciences Appoints Jarrod Longcor as Chief Operating Officer	23/22/23	CI
Kazia Therapeutics Names Chief Medical Officer; Shares Rise 3%	15/21/15	MT
Cellectar Biosciences, Inc. Announces Executive Changes	02/21/02	CI
Cellectar Biosciences, Inc. Announces the Election of Dr. Asher Alban Chanan-Khan to Its Board of Directors	24/21/24	CI
Cellectar Biosciences, Inc. Announces Resignation of Stephen Hill	04/21/04	CI
Cellectar Biosciences, Inc. Appoints John Friend as Chief Medical Officer	01/20/01	CI
Cellectar Biosciences, Inc. Appoints Igor Grachev as Chief Medical Officer	07/20/07	CI
Cellectar Biosciences, Inc. Appoints Dov Elefant as Chief Financial Officer Effective as of September 10, 2019	15/19/15	CI
Cellectar Biosciences, Inc. Appoints Charles T. Bernhardt as Interim Chief Financial Officer, Effective March 9, 2019	09/19/09	CI
Cellectar Biosciences, Inc. Announces the Resignation of Brian M. Posner as Chief Financial Officer, Effective March 8, 2019	16/19/16	CI
Cellectar Biosciences, Inc. Announces Resignation of John E. Friend Ii as Vice President and Chief Medical Officer, Effective November 27, 2018	17/18/17	CI
Cellectar Biosciences Appoints Brian M. Posner as Vice President and Chief Financial Officer	04/18/04	CI
Cellectar Biosciences, Inc. Promotes Jarrod Longcor to Chief Business Officer	18/17/18	CI
Cellectar Biosciences, Inc. Announces Management Changes	19/17/19	CI
Cellectar Biosciences, Inc. Appoints John Friend, II, M.D. as Vice President and Chief Medical Officer Effective April 17, 2017	12/17/12	CI
Cellectar Biosciences, Inc. Appoints Douglas J. Swirsky and Frederick W. Driscoll to Board of Directors	11/17/11	CI
Cellectar Biosciences Appoints Jarrod Longcor as Senior Vice President of Corporate Development and Operations	20/16/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cellectar Biosciences, Inc.

Equities

CLRB

US15117F8077

Insiders

Filters